| Name | Ipafricept | 
|---|
| Description | Ipafricept (OMP-54F28; FZD8-Fc) is the first class of recombinant fusion proteins, consisting of the extracellular portion of the human fried-8 receptor fused to the Fc fragment of human IgG1 binding to the Wnt ligand. Ipafricept shows solid tumor inhibition activity, with well tolerance[1]. | 
|---|---|
| Related Catalog | |
| Target | Wnt ligand[1] | 
| References | 
| No Any Chemical & Physical Properties |